Linden Thomas Advisory Services, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Linden Thomas Advisory Services, LLC

  • $647 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024
BUY
$17.63 - $21.74 $32,280 - $39,805
1,831 Added 1.6%
116,381 $2.3 Billion
Q4 2023

Feb 01, 2024
SELL
$14.37 - $19.07 $19,270 - $25,572
-1,341 Reduced 1.16%
114,550 $2.01 Billion
Q3 2023

Oct 20, 2023
BUY
$13.62 - $20.2 $789,170 - $1.17 Million
57,942 Added 99.99%
115,891 $2.01 Billion
Q2 2023

Jul 27, 2023
BUY
$10.44 - $16.48 $604,987 - $954,999
57,949 New
57,949 $816 Million

Others Institutions Holding KNSA

# of Institutions
11
Shares Held
1.89M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $844M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Linden Thomas Advisory Services, LLC Portfolio

Follow Linden Thomas Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Linden Thomas Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Linden Thomas Advisory Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email